DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20200374

Correlation of serum homocysteine levels in pregnancy related hypertensive disorders versus normotensive pregnancies

Kalki Hymavathi, Neha Shukla, P.V. Sreeleena Madhuri

Abstract


Background: Homocysteine concentrations decrease during normal pregnancy, but this does not occur in pre-eclampsia. In pre-eclampsia, homocysteine levels further increase with severity of pre-eclampsia. Elevated homocysteine levels can be due to genetic or multifactorial deficit or a combination of both.

Methods: The present study is conducted at department of obstetrics and gynaecology, Narayana Medical College and Hospital, Nellore. 200 pregnant (100 women with pregnancy related hypertensive disorders and 100 normotensive pregnants) recruited. Maternal serum Homocysteine levels were analyzed among women with pregnancy related hypertensive disorders and compared with normotensive pregnant. Chemiluminescence immunoassay was used for determining the Homocysteine levels.

Results: The study revealed significant elevation in the levels of homocysteine in pre-eclamptic women (17.54±5.34) compared to normotensive women (7.59±1.91). The study showed a strong association between serum homocysteine levels and severity of pre-eclampsia. The mean homocysteine levels in women with severe Pre-eclampsia (20.59±4.3) were significantly higher than those with mild pre-eclampsia (15.17±1.9). A positive correlation is found between homocysteine levels with serum uric acid and LDH demonstrating the harmful action of hyperhomocysteinemia upon the endothelium. A negative correlation is found between homocysteine levels with hemoglobin and hematocrit even though in anemic patients the hematological levels are found to be little high due to hemoconcentration. The perinatal outcome in women with raised levels of homocysteine was poor with an increased incidence of IUGR (41%), SGA (9%), still births (3%) and IUD (4%) among women with pregnancy related hypertensive disorders when compared to normotensive pregnant women.

Conclusions: Elevated levels of homocysteine can be reduced by administering vitamins which help by increasing the metabolism of homocysteine. The internationally accepted treatment for hyperhomocystenemia is using a combination of folic acid 400 µg, vitamin B12 500 µg and pyridoxine 10mg initiating from pre-conceptional period can be used.


Keywords


Homocysteine, Pregnancy related hypertension, Perinatal outcome

Full Text:

PDF

References


Baumann MU, Bersinger NA, Surbek DV.Serum markers for predicting preeclampsia. Mol Aspects Med. 2007;28:227-44.

Hasanzadeh M, Ayatollahi H, Farzadnia M, Ayati S, Khoob MK. Elevated plasma total homocysteine in preeclampsia. Saudi Med J. 2008;29(6):875.

Yelikar K, Deshpande S, Kulkarni M. Association of maternal serum homocysteine level with severity of preeclampsia: A case control study. Int J Reprod Contracep Obstet Gynecol. 2016;5:2713-7.

Ferdausi M, Khatun M, Yusuf MA, Rahman A, Rahman Z. Association between high serum homocystine and preeclampsia. J Shaheed Suhrawardy Med College. 2013;5(1):21-5.

Falco M, Pollio F, Scaramellino M, Pontillo M, Lieto AD. Homocysteinemia during pregnancy and placental disease. Clin Exp Obstet Gynecol. 2000;27:188-90.

Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obst Gynecol. 2001;185(4):781-5.

Kumari N, Dash K, Singh R. Relationship between maternal age and preeclampsia. IOSR J Dental Med Sci. 2016;15(12):55-7.

Lakshmikumar K, Gomti KD, Shugeta ND, Arbind RS. Effect of age on serum homocysteine level among adult urban population of Manipur. J Med Society. 2013;27(1):46.

Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. Am J Obst Gynecol. 2016;180(3):660-4.

Yelikar KA, Deshpande SS, Kulkarni ML. Association of maternal serum homocysteine level with severity of pre-eclampsia: a case control study. IJRCOG. 2016;5(8):2713-7.

Mansour A, Harb H, Abdelhafeez M. Diagnostic value of homocysteine and other preeclampsia markers: relationship with severity. Int J Biol Chem. 2011;5:227-37.

Khosrowbeygi A, Ahmadvand H. Circulating levels of homocysteine in preeclamptic women. Bangladesh Med Res Council Bulletin. 2011;37(3):106-9.

Qureshi SB, Ahmad M, Qureshi PM, Memon A, Qazi RA. Hyperhomocysteinemia, vascular related pregnancy complications and the response to vitamin supplementation in pregnant women in Pakistan. J Pak Med Assoc. 2010;60(9):741-5.

Noto R, Neri S, Noto Z, Cilio D, Abate G, Noto P, Pepi F, Leanza A, Molino G. Hyperhomocysteinemia in preeclampsia is associated to higher risk pressure profiles. European Review Med Pharmacol Sci. 2003;7:81-7.

Miglani S, Nautiyal R, Prakash A. Hyperhomocysteinemia in pre-eclampsia: is routine screening rational? Int J Repro Contracep Obst Gynecol. 2006;6(4):1272.

Raijmakers MT, Zusterzeel PL, Steegers EA, Peters WH. Hyperhomocysteinaemia: a risk factor for preeclampsia? European J Obst Gynecol Reprod Biol. 2001;95(2):226-8.

Sanlikan F, Tufan F, Gocmen A. The evaluation of homocysteine level in patients with preeclampsia. Ginekol Pol. 2015;86:287-91.

Giguere Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F, Lafond J, Légaré F, Forest JC. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clinical Chemistry. 2010;56(3):361-75.

Zeeman GG, Alexander JM, McIntire DD, Devaraj S, Leveno KJ. Homocysteine plasma concentration levels for the prediction of pre-eclampsia in women with chronic hypertension. Am J Obstet Gynecol. 2003;189:574-6.

Hietala R, Turpeinen U, Laatikainen T. Serum homocysteine at 16 weeks and subsequent preeclampsia. Obstet Gynacol. 2001;97:527-9.

Wenlin MA, Ruhui LIU, Lin LI. The relationship between micro albuminuria and plasma homocysteine level in chinese patients with hypertension. J Hypertens. 2014;3:5.

Micle O, Muresan M, Antal L, Bodog F, Bodog A. The influence of homocysteine and oxidative stress on pregnancy outcome. J Med Life. 2012;5(1):68.

Laskowska M, Oleszczuk J. Homocysteine in pregnancies complicated by preeclampsia with and without IUGR: a comparison with normotensive pregnant women with isolated IUGR and healthy pregnant women. Open J Obst Gynecol. 2011;1:191-6.

Urban J, Jrochi S, Bielechi D, Urban RE. Serum homocysteine and nitric oxide levels in pregnancy complicated with intrauterine fetal growth restriction. Archives Perinatal Med. 2007;13(3):27-9.

Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the hordal and homocysteine study. Am J Clinical Nutrit. 2000;71(4):962-8.

Bergen NE, Jaddoe VW, Timmermabs S, Hofman A, Lindemans J, Russcher H. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the generation study. BJOG. 2012;119(6):739-51.

Basak SK, Begum K, Rashid M, Yasmin N, Begum H. Haematocrit value in preeclampsia. Bangladesh J Obstet Gynaecol. 2015;30(2):80-5.

Sirdah MM, Yassin MM, Shekhi SE, Lubbad AM. Homocysteine and vitamin B 12 status and iron deficiency anemia in female university students from Gaza Strip, Palestine. Revista Brasileira Hematologia Hemoterapia. 2014;36(3):208-12.